Mifepristone and misoprostol are different medicines. This guide explains what mifepristone does, how to read its label and what to discuss with a healthcare professional. Knowing a medicine’s name is not enough to plan treatment.
A question on your mind?
If pregnancy or abortion information feels overwhelming, you can get in touch. We can help with general questions about the information and guides on this site.
Start with a brief question, without sharing your medical history. We don’t provide diagnosis, prescribing or emergency care. If you feel seriously unwell, seek urgent medical help.
How mifepristone differs from misoprostol
Similar subject matter does not make two medicine names synonyms. Understanding the distinct role of an ingredient is the foundation for reading a care explanation, reporting an exposure or asking a pharmacist about a label.
It blocks progesterone activity, which is involved in continuing a pregnancy. The US FDA describes use with misoprostol for ending an intrauterine pregnancy within its approved duration.
Mifepristone and misoprostol are different active ingredients. Keep the medicine names and product instructions distinct when discussing care or reporting what you have taken.
Interpreting the US indication
Regulatory information defines a product’s authorized use within a particular country or region. It should not be read as a worldwide access rule or as evidence that an individual meets the criteria described. Keep the indication and country together when comparing sources.
The US indication covers an intrauterine pregnancy through 70 days from the first day of the last menstrual period. This is US labeling, not a statement of Philippine authorization or individual eligibility.
MedlinePlus distinguishes the pregnancy-related product information from mifepristone used for certain Cushing’s-syndrome-related conditions. Do not transfer one indication’s instructions to another.
Health history and medicine review
An assessment needs more than a pregnancy date. Existing conditions, devices and other treatments can change the questions a professional needs to resolve. Share a complete medicine list through a suitable healthcare service.
FDA contraindications include suspected ectopic pregnancy, certain adrenal conditions, long-term corticosteroid treatment, bleeding disorders or anticoagulant use, inherited porphyria, and relevant allergies. A clinician must assess the actual history.
MedlinePlus says an IUD must be removed before mifepristone treatment. Do not try to remove it yourself; tell the assessing professional that it is present.
MedlinePlus advises discussing all medicines and supplements, including St John’s wort, with a doctor or pharmacist. Do not start, stop or adjust another treatment based only on an online article.
If a precaution is unfamiliar, ask what it means and whether it affects the proposed care. Do not stop an existing treatment or attempt to deal with a device yourself because of an isolated sentence online.
Pregnancy location and urgent symptoms
Safety information should be easy to locate before it is needed. Questions about where a pregnancy is located need separate medical attention; do not assume they are expected effects of treatment.
The FDA labeling excludes confirmed or suspected ectopic pregnancy. Pain, faintness or other concerning symptoms need appropriate assessment rather than an assumption that abortion medicines address every pregnancy location.
MedlinePlus gives soaking two thick full-size pads per hour for two consecutive hours as one emergency warning. Seek help sooner if you feel seriously unwell; this threshold is not a reason to delay care.
MedlinePlus warns about serious illness with weakness, nausea, vomiting, diarrhoea or feeling unwell for more than 24 hours after mifepristone, even without fever. Seek urgent medical advice.
These warning signs mean you should get medical help. Not having one of them does not prove that everything is fine. The safety and ectopic-pregnancy guides provide further context.
Frequently asked questions
What if I vomit, miss a step or remain unsure about the outcome?
Contact the treating service with the medicine name and timing. Do not independently repeat a dose or assume that a change in symptoms confirms completion. Follow the service’s specific completion-check plan.
Can breastfeeding continue after treatment?
NHS Specialist Pharmacy Service considers short-term use compatible with breastfeeding for healthy, full-term infants. Individual advice matters if the baby is premature, unwell or exposed to other medicines.
Sources and references
Check which country and medical situation each source covers. Linking to a source does not mean its publisher endorses this website or has reviewed this article.
Questions and answers on mifepristone
US Food and Drug Administration · US labeling and regulatory program; not Philippine authorization
Source accessed 30 October 2026Open the original source ↗Mifepristone (Mifeprex) drug information
MedlinePlus · US patient medicine information and warning signs
Source accessed 30 October 2026Open the original source ↗Medically terminating a pregnancy during breastfeeding
NHS Specialist Pharmacy Service · Recommendations principally concern healthy, full-term infants
Source accessed 30 October 2026Open the original source ↗